Abstract
Genetic correlation (rg) between traits can offer valuable insight into underlying shared biological mechanisms. Neurodegenerative diseases overlap neuropathologically and often manifest comorbid neuropsychiatric symptoms. However, global rg analyses show minimal rg among neurodegenerative and neuropsychiatric diseases. Importantly, local rg s can exist in the absence of global relationships. To investigate this possibility, we applied LAVA, a tool for local rg analysis, to genome-wide association studies of 3 neurodegenerative diseases (Alzheimer’s disease, Lewy body dementia and Parkinson’s disease) and 3 neuropsychiatric disorders (bipolar disorder, major depressive disorder and schizophrenia). We identified several local rg s missed in global analyses, including between (i) all 3 neurodegenerative diseases and schizophrenia and (ii) Alzheimer’s and Parkinson’s disease. For those local rg s identified in genomic regions containing disease-implicated genes, such as SNCA, CLU and APOE, incorporation of expression quantitative trait loci suggested that genetic overlaps between diseases may be driven by more than one gene. Collectively, we demonstrate that complex genetic relationships exist among neurodegenerative and neuropsychiatric diseases, highlighting putative pleiotropic genomic regions and genes. These findings imply sharing of pathogenic processes and the potential existence of common therapeutic targets.
Competing Interest Statement
AZW served as a medical monitor for Neuroscience Trials Australia, receiving no personal compensation. SWS serves on the scientific advisory council of the Lewy Body Dementia Association and receives grant support from Cerevel Therapeutics.
Funding Statement
This research was funded in whole or in part by Aligning Science Across Parkinson's [Grant numbers: ASAP-000478 and ASAP-000509] through the Michael J. Fox Foundation for Parkinson's Research (MJFF). For the purpose of open access, the author has applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission. AZW was supported through the award of a Clinical Research Fellowship funded by Eisai, Ltd and the Wolfson Foundation. SWS was supported in part by the Intramural Research Program of the U.S. National Institutes of Health (National Institute of Neurological Disorders and Stroke; project number: 1ZIANS003154). SAGT was supported by a Fonds de Recherche du Québec - Santé Junior 1 Award and by operational funds from the Institut de valorisation des données (IVADO). MR was supported through the award of a UKRI Medical Research Council Clinician Scientist Fellowship (MRC Grant Code: MR/N008324/1). JH was supported through the UKRI Medical Research Council (MRC Grant Code: MR/N026004/), the UK Dementia Research Institute, the Dolby Family Fund, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available human data. GWASs used were downloaded from the following sources: Alzheimer's disease, Jansen et al. (https://ctg.cncr.nl/software/summary_statistics); Alzheimer's disease, Kunkle et al. (https://www.niagads.org/igap-rv-summary-stats-kunkle-p-value-data); bipolar disorder (bip2021, https://www.med.unc.edu/pgc/download-results/); Lewy body dementia (https://www.ebi.ac.uk/gwas/studies/GCST90001390); Parkinson's disease (https://pdgenetics.org/resources); major depressive disorder (mdd2019edinburgh, https://www.med.unc.edu/pgc/download-results/), schizophrenia (scz2018clozuk, https://www.med.unc.edu/pgc/download-results/). Cis-eQTL data were obtained from eQTLGen (https://www.eqtlgen.org/cis-eqtls.html) and PsychENCODE (http://resource.psychencode.org). LAVA LD blocks were downloaded from https://github.com/cadeleeuw/lava-partitioning. HapMap Project Phase 3 SNPs and European LD Scores from the 1000 Genomes Project were downloaded from the following Alkes Group repository (https://alkesgroup.broadinstitute.org/LDSCORE/). Human gene annotation (GRCh37, ensembl v87) was downloaded from Ensembl (http://ftp.ensembl.org/pub/grch37/current/gtf/homo_sapiens/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Abstract revised; results and discussion updated to include genetic overlap between AD and PD in HLA region (as reported in: PMID 35684951).
Data Availability
All data produced in the present work are either contained in the manuscript or are made available in the accompanying GitHub repository (https://github.com/RHReynolds/neurodegen-psych-local-corr). GWASs used were downloaded from the following sources: Alzheimer's disease, Jansen et al. (https://ctg.cncr.nl/software/summary_statistics); Alzheimer's disease, Kunkle et al. (https://www.niagads.org/igap-rv-summary-stats-kunkle-p-value-data); bipolar disorder (bip2021, https://www.med.unc.edu/pgc/download-results/); Lewy body dementia (https://www.ebi.ac.uk/gwas/studies/GCST90001390); Parkinson's disease (https://pdgenetics.org/resources); major depressive disorder (mdd2019edinburgh, https://www.med.unc.edu/pgc/download-results/), schizophrenia (scz2018clozuk, https://www.med.unc.edu/pgc/download-results/). Cis-eQTL data were obtained from eQTLGen (https://www.eqtlgen.org/cis-eqtls.html) and PsychENCODE (http://resource.psychencode.org). LAVA LD blocks were downloaded from https://github.com/cadeleeuw/lava-partitioning. HapMap Project Phase 3 SNPs and European LD Scores from the 1000 Genomes Project were downloaded from the following Alkes Group repository (https://alkesgroup.broadinstitute.org/LDSCORE/). Human gene annotation (GRCh37, ensembl v87) was downloaded from Ensembl (http://ftp.ensembl.org/pub/grch37/current/gtf/homo_sapiens/).
Abbreviations
- AD
- Alzheimer’s disease;
- BIP
- bipolar disorder;
- bp
- base pair;
- CI
- confidence interval;
- DLB
- dementia with Lewy bodies;
- eQTL
- expression quantitative loci;
- FDR
- false discovery rate;
- GWAS
- genome-wide association study;
- kb
- kilobase;
- LAVA
- local analysis of [co]variant annotation;
- LBD
- Lewy body dementia;
- LD
- linkage disequilibrium;
- LDSC
- linkage disequilibrium score regression;
- MDD
- major depressive disorder;
- PD
- Parkinson’s disease;
- SCZ
- schizophrenia;
- SNP
- single nucleotide polymorphism;
- UKBB
- UK Biobank;
- ρ
- rho;
- rg
- genetic correlation